Finesse Solutions Announces CellWorld 2015

Santa Clara, California (March 26, 2015) — Finesse Solutions announced CellWorld 2015, a new event that is specifically designed for innovators, visionaries and senior executives in bioprocessing.

The two day conference, by invitation only, will be held at the Hyatt Regency in Downtown San Francisco on September 21-22, 2015. It will be a forum for life science leaders to discuss the future of single-use biopharmaceutical manufacturing and to hear about both disruptive technologies and best practices from all facets of our industry.

The event sessions will cover both upstream and downstream single-use bioprocessing with a focus on innovation through the use of novel measurement and automation systems. It will introduce new tools for managing process complexity and the resulting intelligent meta-data. Topics will range from new single-use sensors to implementing commercial-off-the-shelf, highly configurable manufacturing execution systems (MES) for single-use facilities.

“Our goal is to provide the senior leadership in bioprocessing with a glimpse of the future in order to fully exploit single-use technologies and to remain globally competitive,” stated Barbara Paldus, CEO of Finesse Solutions. “We are very excited to create the first international forum to explore innovation and technology, so that as a community, we can accelerate the adoption of new bioprocessing platforms and fully exploit highly intelligent tools that are rapidly becoming available through advances in electronics, software, and communications.”

About Finesse Solutions, Inc

Finesse Solutions provides flexible hardware and software automation which allows for unmatched customizable bioprocessing. We are a research based, Silicon Valley company who believes in empowering our clients with innovative single-use sensors, bioreactors, controllers and software. Our SmartParts are the foundation of a Finesse solution using technologies from inside and outside of the biopharmaceutical industry. In addition to our own products, we are the only supplier with integration expertise offering clients the independence to select any preferred supplier of key unit operations from upstream to downstream. Whether it’s a stand-alone, single-use bioreactor for research and development or a fully integrated SmartFactory for cGMP-compliant manufacturing, we have a bioprocess solution for our customers.

For more information, please visit us at finesse.com/cellworld/

Media: Richard Ferraro, Director Marketing and Communications
408 206 6281 Rferraro@Finesse.com